财务业绩 - 公司第三季度销售额为48,393,000美元，较上年同期下降2.9%[61] - 国内销售额为35,523,000美元，与上年同期基本持平[61] - 国际销售额为12,870,000美元，较上年同期下降10.7%[61] - 第三季度毛利率为25.8%，较上年同期提高1.9个百分点[62] - 第三季度营业费用为9,913,000美元，占销售额20.5%，较上年同期上升4.2个百分点[63] - 第三季度净利润为2,193,000美元，较上年同期下降11.4%[65] 订单情况 - 公司订单总额为159.4百万美元，较上年同期增加13.2%[61] 未来展望 - 公司预计未来需求受实验室建设项目进度影响较大[68] - 公司将继续专注于支持国内经销商和分销渠道合作伙伴[69] - 公司整体经营状况良好,有望保持稳定发展[69]

Kewaunee Scientific Corporation (KEQU) reported mixed results for first-quarter fiscal 2025, with both earnings per share (EPS) and sales declining year over year. The company faced headwinds from delayed international shipments, particularly in India, which weighed on its overall performance.However, domestic operations were stable in the quarter under review, and a growing order backlog suggests the potential for recovery in the coming quarters. Rising costs, driven by higher professional fees, also impac ...

财务业绩 - 第一季度销售额为48,393,000美元，同比下降2.9%[2] - 税前利润为2,430,000美元，同比下降28.8%[2] - 净利润为2,193,000美元，同比下降11.4%[2] - EBITDA为3,325,000美元，同比下降22.8%[2] - 每股摊薄收益为0.74美元，同比下降14.0%[2] - 公司净销售额为4839万美元，较上年同期下降3.0%[17] - 毛利润为1249万美元，较上年同期增加4.8%[17] - 营业利润为258万美元，较上年同期下降32.4%[17] - 净收益为219万美元，较上年同期下降11.4%[17] - 每股基本收益为0.77美元，每股摊薄收益为0.74美元[17] 订单情况 - 订单积压为1.594亿美元，较上年同期增加13.2%[2] 区域销售 - 国内销售额为35,523,000美元，同比增长0.3%[3] - 国际销售额为12,870,000美元，同比下降10.7%[3] 财务状况 - 公司现金余额为2,518.6万美元，较上季度末减少2.9%[5] - 公司债务权益比为0.68:1，较上季度末有所改善[6] - 现金及现金等价物为2421万美元，较上年同期增加4.1%[19,20] - 应收账款余额为4355万美元，较上年同期下降3.4%[19,20] - 存货余额为1929万美元，较上年同期下降6.7%[19,20] - 总资产为13202万美元，较上年同期下降2.0%[19,20] - 总负债为7451万美元，较上年同期下降5.2%[19,20]

STATESVILLE, N.C., Sept. 11, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its first quarter ended July 31, 2024.Fiscal Year 2025 First Quarter Results:Sales during the first quarter of fiscal year 2025 were $48,393,000, a decrease of 2.9% compared to sales of $49,839,000 from the prior year's first quarter. Pre-tax earnings for the quarter were $2,430,000 compared to $3,412,000 for the prior year quarter, a decrease of 28.8%. Net earnings were $2,193,000 co ...

STATESVILLE, N.C., Sept. 4, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, today announces that the Company will attend the 2024 Arablab Live tradeshow and conference being held in Dubai this September 24-26. The tradeshow will welcome industry professionals from 120+ countries, bringing together leading global designers, manufacturers, and distributors i ...

STATESVILLE, N.C., Aug. 28, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its first quarter fiscal year 2025 financial results on Wednesday, September 11, 2024 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release.About Kewaunee Scientific Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of labo ...

LOS ANGELES, Aug. 8, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kewaunee Scientific Corporation ("Kewaunee Scientific" or "the Company") (NASDAQ: KEQU)  for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.If you are a shareholder who suffered a loss, click her ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________________________ FORM 10-K __________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number 0-5286 KEWAUNEE SCIENTIFIC CORPORATION (Exact name of reg ...

Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. June 26, 2024 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2024. Fiscal Year 2024 Fourth Quarter Results: Sales during the fourth quarter of fiscal year 2024 were $56,702,000, an increase of 5% compared to sales of $53,986,000 from the prior year's fourth ...

STATESVILLE, N.C., June 26, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2024. Fiscal Year 2024 Fourth Quarter Results: Sales during the fourth quarter of fiscal year 2024 were $56,702,000, an increase of 5% compared to sales of $53,986,000 from the prior year's fourth quarter. Pre-tax earnings for the quarter were $1,347,000 compared to $2,322,000 for the prior year quarter. Net earnings for the quarte ...